Pathological analysis of brain tumors using FDG and 11C-methionine PET

Pathological analysis of brain tumors using FDG and 11C-methionine PET - Pathological analysis of brain tumors using FDG and 11C-methionine PET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007672

Enrollment

100

Registered

2012-04-05

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumors

Interventions

11C-methinoine PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients harboring either meningiomas or gliomas

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Imaging and analysis of tumor cell invasion into the white matter	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026